Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicentre outcomes study of antiemetic practice for chemotherapy-induced nausea and vomiting
NL-OMON27981Active, not recruiting
- Sponsor
- Noordwest Ziekenhuisgroep Hospital Pharmacy
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by Noordwest Ziekenhuisgroep Hospital Pharmacy. Primary endpoints: Inventory of antiemetic policy and Effectiveness of antiemetic policies. Started Apr 2005; status: active, not recruiting.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NL-OMON27981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27981.